CD8A and glioblastoma: These findings align with those of our recent investigation, wherein we observed that polyamine blockade facilitated the infiltration of CD8+ T cells and synergistically enhanced animal survival when combined with anti-PD1 or anti–PD-L1 immunotherapy in murine models of glioblastoma (117).